Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,293 public trials 1,198 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

Phase 2 Study of AUY922 in NSCLC Patients With Exon 20 Insertion Mutations in EGFR

NCT01854034

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer

NCT00654030

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Commonwealth Cancer Center Danville, Kentucky, United States
  • University of Kentucky Lexington, Kentucky, United States
  • University of Louisville Hospital Louisville, Kentucky, United States
  • Owensboro Medical Health System Owensboro, Kentucky, United States
View Trial Details
Completed

BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation

NCT00949650

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +11 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Clinical Trials and Research Associates Inc Montebello, California, United States
  • Innovative Medical Research of South Florida Miami, Florida, United States
  • Crescent City Research Consortiom Marrero, Louisiana, United States
View all 133 locations
View Trial Details
Completed

Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer

NCT00111839

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • University of Arkansas, Arkansas Cancer Research Center Little Rock, Arkansas, United States
  • University of Southern California/Norris Cancer Center Los Angeles, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
View all 58 locations
View Trial Details
Completed

Erlotinib Plus Tivantinib (ARQ 197) Versus Single Agent Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT01395758

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Stanford, California, United States
  • Washington D.C., District of Columbia, United States
  • Weston, Florida, United States
  • Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Completed

AUY922 for Advanced ALK-positive NSCLC

NCT01752400

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions